Virtually all higher eucaryotic cells rapidly depress synthesis of new a-and /~-tubulin polypeptides in response to microtubule inhibitors that increase the pool of depolymerized subunits. This apparently autoregulatory control of tubulin synthesis is achieved through modulation of tubulin messenger RNA levels. In particular, in cells treated with the microtubule-depolymerizing drug colchicine, tubulin messenger RNAs are specifically and rapidly lost from the cell cytoplasm. A priori this loss may be the result of suppression of new tubulin RNA transcription, failure of newly synthesized tubulin RNAs to be properly processed or transported from the nucleus, or an increased rate of cytoplasmic tubulin RNA degradation. Although transcriptional regulation has been demonstrated for most cellular eucaryotic genes thus far investigated in detail, we found that the apparent rates of tubulin RNA transcription were essentially unchanged in isolated nuclei derived from colchicine treated or control cells. This finding argues that the principal control of tubulin gene expression in response to altered subunit pools is probably not achieved through a transcriptionally regulated mechanism.Although it seems clear a priori that the synthesis of cytoskeletal proteins must be correlated with cell growth and differentiation, the mechanism(s) through which this regulation is achieved has received little attention. Recently, however, a number of reports have demonstrated dramatic modulation of tubulin synthesis with cellular morphological changes (1,3,8,27). In particular, the provocative report of Ben Ze'ev et al. (3) demonstrated that colchicine, which depolymerizes microtubules and raises the level of tubulin subunits in the cell (28), causes a cessation oftubulin synthesis within 6 h. In contrast, vinblastine, a drug that causes depolymerization followed by "precipitation" of the tubulin subunits (2, 5, 13) results in a small increase in new synthesis. Together, these observations suggest that the level of unpolymerized tubulin subunits modulates the level of new tubulin synthesis. We subsequently extended this initial observation to determine that the kinetics of the cellular response to a wide range of antitubulin drugs is rapid (with a half time of 1-1.5 h) and that this is a general phenomenon occurring in virtually all higher eucaryotic cells (8).Conceptually, this apparent autoregulatory control of tubulin synthesis may be achieved through any of the following general molecular mechanisms: (a) translational sequestration or reversible inactivation of tubulin messenger RNAs (mRNAs), ~ (b) transcriptional modulation of tubulin genes, I Abbreviations used in this paper: cDNA, complementary DNA; CHO, Chinese hamster ovary; mRNA, messenger RNA; UTP, uridine triphosphate.
We have previously demonstrated that the chicken genome contains at least four different, functional beta-tubulin genes. By using gene specific probes we have now analyzed the relative levels of expression of the four encoded messenger RNA (mRNA) transcripts as a function of chicken development and differentiation. We have found that the RNA transcript from the beta 2 gene is present in large amounts in embryonic chick brain and is also preferentially expressed in spinal cord neurons, indicating that this transcript encodes the dominant neuronal beta-tubulin polypeptide. The beta 3 mRNA is present in overwhelming amounts in RNA from chicken testis suggesting that this gene encodes a flagellar or meiotic spindle tubulin. However, both of these genes are transcribed to varying, but lesser, degrees in a number of additional cell and tissue types indicating that they are not neuronal or testis specific, respectively. Beta 4' transcripts are present at moderate levels in all cell and tissue types examined, suggesting that this mRNA encodes a constitutive beta-tubulin polypeptide that is involved in an essential or housekeeping microtubule function. Transcripts from the beta 1 gene are a minor component of the beta-tubulin mRNA populations in all cells and tissues tested. Overall, we conclude that specific beta-tubulin mRNA species are expressed in markedly different ratios in different tissues in the chicken. Such developmental regulation may reflect the function(s) of the individual beta-tubulin polypeptides or, alternatively, may be required for precise control of tubulin gene expression in cells that utilize microtubules for divergent purposes.
Schistosoma mansoni-infected individuals who have low intensities of reinfection following treatment produce immunoglobulin E (IgE) antibodies against a range of S. mansoni adult-worm antigens. One of the targets of the IgE response is an adult-worm sodium dodecyl sulfate-polyacrylamide gel electrophoresis band of 22 kDa (Sm22), which contains an antigen(s) located within the tegument and gut lining of adult worms and relatively late schistosomula life cycle stages only. A significant negative correlation between the level of anti-Sm22 IgE and the intensity of reinfection following treatment suggests that IgE responses against this antigen(s) are characteristic of individuals who are resistant to reinfection. To identify the antigen(s) in the Sm22 band that are associated with these IgE responses, we have cloned and characterized a recombinant 22-kDa protein (rSm22) that cross-reacts immunologically with Sm22. There was a high correlation between native and recombinant Sm22 isotype responses, indicating that the correct antigen had been cloned and that responses against rSm22 made up the majority of the responses against Sm22. By analyzing human isotype responses to rSm22 with human sera from a longitudinal treatment and reinfection study and correlating the anti-rSm22 isotype responses, retrospectively, with the intensity of reinfection following treatment for each individual, we observed a negative correlation between the IgE response to rSm22 and the intensity of reinfection. This relationship remained significant after allowing for age and other isotype responses to rSm22, in particular IgG4.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.